Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice.
Chronic myelomonocytic leukemia (CMML): a genetically heterogeneous entity.
Modeling cholesterol metabolism by gene expression profiling in the hippocampus.
Evaluation of emphysema on thoracic low-dose CTs through attention-based multiple instance deep learning.
Precision pharmacology for Alzheimer's disease.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision pharmacology for Alzheimer's disease.
Precision pharmacology for Alzheimer's disease. Pharmacol Res. 2018 04; 130:331-365.
View in:
PubMed
subject areas
Alzheimer Disease
Amyloid beta-Peptides
Animals
Biomarkers
Drug Discovery
Humans
Precision Medicine
tau Proteins
authors with profiles
George Perry